Healthcare
Inventure et al exit Proxeon to Thermo Fisher Scientific
Inventure Capital, Vecata and Vækstfonden have divested their stake in scientific instrument maker Proxeon A/S to US trade buyer Thermo Fisher Scientific Inc. The terms of the deal were not disclosed.
Duke Street and Partners inject a further £30m into Oasis
Duke Street and Partners Group are backing dental chain Oasis Healthcare development plans. The fresh equity capital and a new acquisition facility will give Oasis access to up to £50m of growth capital to upgrade its existing estate, acquire established...
CDC Enterprises in $18m round for biospace med
CDC Entreprises, (acting on behalf of the Strategic Investment Fund -SIF), has participated in an $18m round for biospace med alongside existing investors Edmond de Rothschild Investment Partners, Crédit Agricole Private Equity, UFG Private Equity, NBGI...
HTGF and KI Kapital invest in SAW Instruments
High-Tech Gründerfonds and KI Kapital GmbH have invested in start-up SAW Instruments GmbH.
Gimv hires DACH life sciences partner
Gimv has hired Annegret de Baey-Diepolder as a partner to join the firm’s life sciences in the DACH region; she will be base in Munich.
Norinnova and Sarsia Seed back Prophyllix Pharma,
Norinnova Forvaltning, via Norinnova Invest, has alongside Sarsia Seed invested in Norwegian life science company Prophyllix Pharma, each taking a 7.7% stake.
Synova appoints new investment director
UK low to mid-market investor, Synova Capital LLP, has appointed Dr Joe Wiley as an investment director and head of healthcare.
Arax backs Biocrates Life Science with €1.2m
Arax Capital Partners has funded metabolic biomarker company Biocrates Life Science AG with €1.2m as a first tranche of a fundraising round.
Riverside acquires Eska Implants for Summit Medical
The Riverside Company has acquired German Eska Implants AG as a bolt-on for its UK-based portfolio company Summit Medical Group Limited.
Aescap et al. in €30m Biocartis round
Aescap, alongside other existing backers and new strategic investors Debiopharm Group and Johnson & Johnson, has particpated in a €30m series B funding round for Biocartis SA.
Lyceum Capital-backed Carewatch completes three bolt-ons
Lyceum Capital-backed Carewatch, a provider of domiciliary care services, has acquired three more businesses in the sector: Midlands-based homecare organisation All and Small and two current franchise businesses Carewatch North Tyneside and Carewatch...
Graphite invests further £24m in Willowbrook
UK mid-market player Graphite Capital has invested a further £24m in Willowbrook Healthcare, part of a development capital package to support a major expansion programme.
Abingworth invests in €33m round for Epigenomics
Abingworth has invested in listed biotech company Epigenomics AG as part of an oversubscribed €33.1m fundraising round.
EnjoyVenture leads funding for amedo Smart Tracking
EnjoyVenture has led a follow-on round of funding for amedo Smart Tracking Solutions, alongside High-Tech Gründerfonds, the KfW banking group and new strategic investors.
KKR invests in Ambea as co-lead with Triton
US-based KKR has joined Triton in its investment in Nordic healthcare specialist Ambea.
Boehringer Ingelheim launches €100m corporate venture fund
Pharmaceuticals giant Boehringer Ingelheim has launched the Boehringer Ingelheim Venture Fund, a €100m corporate venture vehicle.
Gimv in series-B round for JenaValve
Gimv has participated in a €19m series-B financing round of German company JenaValve, alongside Atlas Venture, Edmond de Rothschild Investment Partners, Neomed Management, VI Partners and Sunstone Capital.
August committs further £23m to bulk up First Call
August Equity has committed a further £23m to fund the merger of its existing portfolio company First Call Services to Active Assistance.
High Tech Beteiligungen sells Mika Pharma to Giuliani
High Tech Beteiligungen GmbH has sold its entire equity interest in Mika Pharma GmbH to Milan-based pharmaceutical company Giuliani SpA for an undisclosed amount.
Valedo exits Solhaga in SBO to Bridgepoint
Valedo Partners has sold health care business Solhaga to Bridgepoint Development Capital.
HTGF invests €500,000 in Humedics
High-Tech Gründerfonds has invested €500,000 in Humedics, a spin-off from Freie Universität Berlin and the Charité University Hospital.
Montagu cancels BSN Medical IPO
Reports suggest that Montagu Private Equity has cancelled its plans to list medical supplies company BSN Medical due to continuing difficulties with capital markets.
Sovereign Capital backs £10m MBO of RehabWorks
Sovereign Capital has backed the £10m management buyout of rehabilitation services provider RehabWorks Limited.
Future Capital et al. sell IEP to Cambrex
Future Capital, Heidelberg Capital and SET have sold enzyme provider IEP GmbH to trade buyer Cambrex Corporation.